Stephane Gerard Pichon

Managing Partner at Your Care Consult
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Greater Paris Metropolitan Region, FR
Languages
  • English Native or bilingual proficiency
  • French Native or bilingual proficiency
  • German Limited working proficiency
  • Swedish Limited working proficiency
  • Spanish Elementary proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 2 ratings
  • (2)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Filippo Rean

I've been knowing Stephane since the time we were both at GE Capital, and always appreciated his commitment and passion for results. In the last few years, Stephane has actively contributed to Mipim, sharing his recognised knowledge on the healthcare property sector during our market in Cannes, leading a conferençe on the subject that has become a key event in the busy Mipim agenda of many real estate professionals.

Ignacio M.

I reported directly to Stephane at GE, and I consider him a very high qualified manager, with exceptional financial skills, impressive knowledge of the Healthcare and Real Estate sectors in Europe, and an extensive professional network. He is dynamic and creative in building strong relationships with clients and in identifying new deals. Stéphane also has extensive language skills and the ability to quickly adapt to new contexts and challenges and to efficiently work with and lead teams. Stéphane is a highly qualified executive and, above all, a great person and a loyal friend.

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • MRICS
    RICS
    Jul, 2014
    - Nov, 2024

Experience

    • France
    • Financial Services
    • 1 - 100 Employee
    • Managing Partner
      • Jul 2009 - Present

      Mission: To assist care operators (long-term care, acute, medtech ...) in their development. • Advisor to: ◊ financial investors (due diligences) ◊ acute and long-term care operators ◊ real estate investors • Capital and debt raising • Quality building solutions • Expert consulting on: ◊ energy efficiency and production of green electricity ◊ operations productivity advisory • Advised Maisons de Famille on acquisition of 2 French long-term care facilities • Finder of piece of land for creation of assisted living facility in Normandie by Groupe Steva • Achieved authorisation transfer for CS3 Santé Media further to purchase of assets of Clinique du Bien Naître (Paris) • Appraised of Nursing Home RE in Paris region for Seniors Concept • Sold Technosens'TV-based two-way communication to Nursing Home operator • Analysis of French healthcare market and property tour of nursing homes and clinics in Paris region for Cornerstone Show less

    • Vice-President Business Development
      • Apr 2005 - Jun 2009

      • Managed healthcare real estate financings and investments in South-Western Europe. • Led two relationship managers respectively focused on Spain and Italy. • Took minority equity stake in Gecimed, Europe’s first healthcare-dedicated Real Estate Investment Trust. • Managed healthcare real estate financings and investments in South-Western Europe. • Led two relationship managers respectively focused on Spain and Italy. • Took minority equity stake in Gecimed, Europe’s first healthcare-dedicated Real Estate Investment Trust.

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Senior Manager Business Development
      • Mar 2002 - Mar 2005

      • Managed origination and execution of European acquisitions in IT, cardiology, molecular imaging. • Acquired Amersham, British leader in molecular medicine, for €9 billion. • Acquired Instrumentarium, Finnish leader in anaesthesia equipment, for €2 billion. • Acquired two GE Healthcare distributors to ensure direct presence in strategic markets (Scandinavia and Middle East). • Managed origination and execution of European acquisitions in IT, cardiology, molecular imaging. • Acquired Amersham, British leader in molecular medicine, for €9 billion. • Acquired Instrumentarium, Finnish leader in anaesthesia equipment, for €2 billion. • Acquired two GE Healthcare distributors to ensure direct presence in strategic markets (Scandinavia and Middle East).

    • Capital Markets
    • 700 & Above Employee
    • Director, Corporate Finance
      • Sep 1999 - Jan 2002

      • Led 12-member team focusing on the origination and execution of deals in France. • Advised biotech company on a dual track IPO vs. sale to a strategic buyer. • Participated on team that acted as principal along with two financial partners to acquire property development company CGIS, subsequently renamed Nexity, for €850 million. • Advised leading French ISP Wanadoo on €2.7 billion recommended offer for leading UK ISP Freeserve. • Advised Zodiac on the €460 million acquisition (public takeover and squeeze-out) of Intertechnique. • Led €88 million’s InfoVista follow-on offering, first ever in the Nouveau Marché where the secondary component of an offering containing primary shares was not conditioned to the ‘10/20’ pricing rule. • Led InfoVista’s €76 million 19x oversubscribed IPO, with a dual Nouveau Marché / Nasdaq listing. • Led Valtech’s €72.5 million capital increase and its €163 million acquisition of Danish company Ahead. • Co-managed Alcatel Optronics €1.7 billion offering of Class O shares (first European tracking stock). • Co-managed Thomson Multimedia’s €2.7 billion follow-on primary and secondary share offering. Show less

    • Switzerland
    • Financial Services
    • 700 & Above Employee
    • Associate Director, Corporate Finance
      • Aug 1997 - Aug 1999

      • Led €1.1 billion Rhône-Poulenc (now part of Sanofi-Aventis) spin-off and IPO of Rhodia (dual Paris / NYSE listing) and advised on pre-IPO disposal of its PCC business. • Advised biotech company on capital raising exercise through convertible bonds. • Performed two fairness opinions for Suez on transactions aggregating €1 billion. • Led €1.1 billion Rhône-Poulenc (now part of Sanofi-Aventis) spin-off and IPO of Rhodia (dual Paris / NYSE listing) and advised on pre-IPO disposal of its PCC business. • Advised biotech company on capital raising exercise through convertible bonds. • Performed two fairness opinions for Suez on transactions aggregating €1 billion.

    • Financial Analyst
      • 1992 - 1995

      • Managed 9-member team that designed and prepared inaugural report on Park’s activities. • Participated in formulation of business plans, which resulted in a profit turnaround of $1.1 billion. • Led task force to streamline staff recruiting and scheduling procedures as part of a business process re-engineering program that reduced operating costs by $60 million. • Developed statistical models that enhanced accuracy of weekly attendance forecasts by 15% and reduced analysis time of Pan-European customer profile by 70%. Show less

    • Financial Controller
      • 1990 - 1991

      Subsidiary with annual sales of $100 million of French manufacturer of aluminum and packaging products • In charge of accounting, financial controlling, budgeting and monthly reporting to Parent Company. Subsidiary with annual sales of $100 million of French manufacturer of aluminum and packaging products • In charge of accounting, financial controlling, budgeting and monthly reporting to Parent Company.

Education

  • University of Pennsylvania - The Wharton School
    Master of Business Administration, Finance and accounting
    1995 - 1997
  • Rouen Business School / ESC Rouen
    Bachelor of Business Administration, International Business
    1987 - 1990

Community

You need to have a working account to view this content. Click here to join now